研究表明,药物LSD版本MM120可以显著减少12个星期的焦虑。 Study shows MM120, a pharmaceutical LSD version, can significantly reduce anxiety for up to 12 weeks.

在《美国医学协会杂志》上公布的一项研究表明,100毫克剂量MM120(药物版LSD)可显著减少普遍焦虑症患者的焦虑症状,时间最长可达12周。 A study published in the Journal of the American Medical Association shows that a 100 microgram dose of MM120, a pharmaceutical version of LSD, may significantly reduce anxiety symptoms in patients with generalized anxiety disorder for up to 12 weeks. 大多数参加者经历的轻微幻觉在12小时内得到解决。 Most participants experienced mild hallucinations that resolved within 12 hours. 制毒者Mindmed计划进一步进行试验,以寻求林业发展局的批准,这标志着用迷幻药物治疗焦虑症的潜在转变。 The drugmaker, Mindmed, plans further trials to seek FDA approval, marking a potential shift in the treatment of anxiety disorders with psychedelic drugs.